Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Metachronous Bilateral Vestibular Schwannomas.

Elsayed M, Hochet B, Torres R, Sterkers O, Nguyen Y, Lahlou G, Kalamarides M.

Laryngoscope. 2020 Feb 17. doi: 10.1002/lary.28571. [Epub ahead of print]

PMID:
32065398
2.

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.

Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyrière H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honoré S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL.

Clin Cancer Res. 2020 Feb 1;26(3):552-557. doi: 10.1158/1078-0432.CCR-19-2109. Epub 2020 Jan 22.

PMID:
31969329
3.

Response to: "what is the advantage of using sodium fluorescein during resection of peripheral nerve tumors?"

Peyre M, Kalamarides M.

Acta Neurochir (Wien). 2020 Jan 6. doi: 10.1007/s00701-019-04211-w. [Epub ahead of print] No abstract available.

PMID:
31907613
4.

Mechanical thrombectomy in acute ischemic stroke patients under venoarterial extracorporeal membrane oxygenation.

Le Guennec L, Schmidt M, Clarençon F, Elhfnawy AM, Baronnet F, Kalamarides M, Lebreton G, Luyt CE.

J Neurointerv Surg. 2019 Nov 19. pii: neurintsurg-2019-015407. doi: 10.1136/neurintsurg-2019-015407. [Epub ahead of print]

PMID:
31744852
5.

Extracapsular dissection in peripheral nerve schwannoma surgery using bright light and fluorescein sodium visualization: case series.

Kalamarides M, Bernat I, Peyre M.

Acta Neurochir (Wien). 2019 Dec;161(12):2447-2452. doi: 10.1007/s00701-019-04071-4. Epub 2019 Nov 2.

PMID:
31679103
6.

Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.

Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Özduman K, Sheth AH, Zhao AY, Tyrtova E, Miyagishima DF, Fomchenko EI, Hong CS, Clark VE, Riche M, Peyre M, Boetto J, Sohrabi S, Koljaka S, Baranoski JF, Knight J, Zhu H, Pamir MN, Avşar T, Kilic T, Schramm J, Timmer M, Goldbrunner R, Gong Y, Bayri Y, Amankulor N, Hamilton RL, Bilguvar K, Tikhonova I, Tomak PR, Huttner A, Simon M, Krischek B, Kalamarides M, Erson-Omay EZ, Moliterno J, Günel M.

J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266. [Epub ahead of print]

PMID:
31653806
7.

Management of sporadic vestibular schwannoma with contralateral nonserviceable hearing.

Jia H, Nguyen Y, De Seta D, Hochet B, Smail M, Bernardeschi D, Wu H, Mosnier I, Kalamarides M, Sterkers O.

Laryngoscope. 2019 Oct 23. doi: 10.1002/lary.28369. [Epub ahead of print]

PMID:
31643090
8.

NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.

Jia H, Nguyen Y, Hochet B, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D.

Otol Neurotol. 2020 Jan;41(1):94-99. doi: 10.1097/MAO.0000000000002431.

PMID:
31634276
9.

How to radiologically identify a spontaneous regression of sporadic vestibular schwannoma?

Lahlou G, Rodallec M, Nguyen Y, Sterkers O, Kalamarides M.

PLoS One. 2019 Jun 4;14(6):e0217752. doi: 10.1371/journal.pone.0217752. eCollection 2019.

10.

Surgery of the lateral skull base: a 50-year endeavour.

Zanoletti E, Mazzoni A, Martini A, Abbritti RV, Albertini R, Alexandre E, Baro V, Bartolini S, Bernardeschi D, Bivona R, Bonali M, Borghesi I, Borsetto D, Bovo R, Breun M, Calbucci F, Carlson ML, Caruso A, Cayé-Thomasen P, Cazzador D, Champagne PO, Colangeli R, Conte G, D'Avella D, Danesi G, Deantonio L, Denaro L, Di Berardino F, Draghi R, Ebner FH, Favaretto N, Ferri G, Fioravanti A, Froelich S, Giannuzzi A, Girasoli L, Grossardt BR, Guidi M, Hagen R, Hanakita S, Hardy DG, Iglesias VC, Jefferies S, Jia H, Kalamarides M, Kanaan IN, Krengli M, Landi A, Lauda L, Lepera D, Lieber S, Lloyd SLK, Lovato A, Maccarrone F, Macfarlane R, Magnan J, Magnoni L, Marchioni D, Marinelli JP, Marioni G, Mastronardi V, Matthies C, Moffat DA, Munari S, Nardone M, Pareschi R, Pavone C, Piccirillo E, Piras G, Presutti L, Restivo G, Reznitsky M, Roca E, Russo A, Sanna M, Sartori L, Scheich M, Shehata-Dieler W, Soloperto D, Sorrentino F, Sterkers O, Taibah A, Tatagiba M, Tealdo G, Vlad D, Wu H, Zanetti D.

Acta Otorhinolaryngol Ital. 2019 Jun;39(SUPPL. 1):S1-S146. doi: 10.14639/0392-100X-suppl.1-39-2019.

11.

Neurofibromatosis type 2: Hearing preservation and rehabilitation.

Jia H, El Sayed MME, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D.

Neurochirurgie. 2018 Nov;64(5):348-354. doi: 10.1016/j.neuchi.2018.09.003. Epub 2018 Oct 9. Review.

PMID:
30314805
12.

TERT, the target?

Sahm F, Kalamarides M.

Neuro Oncol. 2018 Nov 12;20(12):1561-1562. doi: 10.1093/neuonc/noy138. No abstract available.

13.

Neurofibromatosis type 2: A challenge for the neurosurgical medical community.

Kalamarides M.

Neurochirurgie. 2018 Nov;64(5):333-334. doi: 10.1016/j.neuchi.2018.09.001. Epub 2018 Sep 19. No abstract available.

PMID:
30243463
14.

A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas.

Rosenberg S, Simeonova I, Bielle F, Verreault M, Bance B, Le Roux I, Daniau M, Nadaradjane A, Gleize V, Paris S, Marie Y, Giry M, Polivka M, Figarella-Branger D, Aubriot-Lorton MH, Villa C, Vasiljevic A, Lechapt-Zalcman E, Kalamarides M, Sharif A, Mokhtari K, Pagnotta SM, Iavarone A, Lasorella A, Huillard E, Sanson M.

Nat Commun. 2018 Jun 18;9(1):2371. doi: 10.1038/s41467-018-04622-w.

15.

Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.

Boetto J, Apra C, Bielle F, Peyre M, Kalamarides M.

Oncogene. 2018 Sep;37(36):4955-4963. doi: 10.1038/s41388-018-0328-7. Epub 2018 May 22.

16.

Psychological follow-up care of neurofibromatosis type 2 patients and their relatives.

Carillo C, Kiening M, Bergheimer S, Kalamarides M.

Neurochirurgie. 2018 Nov;64(5):381-385. doi: 10.1016/j.neuchi.2016.09.008. Epub 2018 May 10. Review.

PMID:
29754738
17.

Pazopanib efficacy in recurrent central nervous system hemangiopericytomas.

Apra C, Alentorn A, Mokhtari K, Kalamarides M, Sanson M.

J Neurooncol. 2018 Sep;139(2):369-372. doi: 10.1007/s11060-018-2870-0. Epub 2018 Apr 26.

18.

2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.

Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, Martin S, Morrison H, Pasmant E, Ratner N, Schorry E, Ullrich NJ, Viskochil D, Weiss B, Widemann BC, Zhu Y, Bakker A, Serra E.

Am J Med Genet A. 2018 May;176(5):1258-1269. doi: 10.1002/ajmg.a.38675.

19.

Natural history of cavernous sinus meningiomas.

Amelot A, van Effenterre R, Kalamarides M, Cornu P, Boch AL.

J Neurosurg. 2018 Mar 1:1-8. doi: 10.3171/2017.7.JNS17662. [Epub ahead of print]

PMID:
29600913
20.

Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.

Louvrier C, Pasmant E, Briand-Suleau A, Cohen J, Nitschké P, Nectoux J, Orhant L, Zordan C, Goizet C, Goutagny S, Lallemand D, Vidaud M, Vidaud D, Kalamarides M, Parfait B.

Neuro Oncol. 2018 Jun 18;20(7):917-929. doi: 10.1093/neuonc/noy009.

21.

Current treatment options for meningioma.

Apra C, Peyre M, Kalamarides M.

Expert Rev Neurother. 2018 Mar;18(3):241-249. doi: 10.1080/14737175.2018.1429920. Epub 2018 Jan 22. Review.

22.

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.

Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M.

Neuro Oncol. 2018 Jul 5;20(8):1113-1121. doi: 10.1093/neuonc/nox231.

23.

Progestin-associated shift of meningioma mutational landscape.

Peyre M, Gaillard S, de Marcellus C, Giry M, Bielle F, Villa C, Boch AL, Loiseau H, Baussart B, Cazabat L, Raffin-Sanson ML, Sanson M, Kalamarides M.

Ann Oncol. 2018 Mar 1;29(3):681-686. doi: 10.1093/annonc/mdx763.

24.

Spinal ependymomas in NF2: a surgical disease?

Kalamarides M, Essayed W, Lejeune JP, Aboukais R, Sterkers O, Bernardeschi D, Peyre M, Lloyd SK, Freeman S, Hammerbeck-Ward C, Kellett M, Rutherford SA, Evans DG, Pathmanaban O, King AT.

J Neurooncol. 2018 Feb;136(3):605-611. doi: 10.1007/s11060-017-2690-7. Epub 2017 Nov 29.

PMID:
29188529
25.

Spontaneously Resolving Symptomatic Subdural Hygromas After Cerebellopontine Angle Tumor Surgery.

Lefevre E, Montero AS, Bernardeschi D, Kalamarides M.

World Neurosurg. 2018 Feb;110:35-38. doi: 10.1016/j.wneu.2017.10.114. Epub 2017 Oct 31.

PMID:
29101072
26.

Intracranial solitary fibrous tumors/hemangiopericytomas: first report of malignant progression.

Apra C, Mokhtari K, Cornu P, Peyre M, Kalamarides M.

J Neurosurg. 2018 Jun;128(6):1719-1724. doi: 10.3171/2017.1.JNS162593. Epub 2017 Jun 23.

27.

Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.

Peyre M, Feuvret L, Sanson M, Navarro S, Boch AL, Loiseau H, Kalamarides M.

J Neurooncol. 2017 Jul;133(3):633-639. doi: 10.1007/s11060-017-2480-2. Epub 2017 May 23.

PMID:
28536991
28.

A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas.

Goutagny S, Giovannini M, Kalamarides M.

J Neurooncol. 2017 Jun;133(2):443-445. doi: 10.1007/s11060-017-2447-3. Epub 2017 Apr 22. No abstract available.

PMID:
28434114
29.

Role of electrophysiology in guiding near-total resection for preservation of facial nerve function in the surgical treatment of large vestibular schwannomas.

Bernardeschi D, Pyatigorskaya N, Vanier A, Bielle F, Smail M, Lamas G, Sterkers O, Kalamarides M.

J Neurosurg. 2018 Mar;128(3):903-910. doi: 10.3171/2016.11.JNS161737. Epub 2017 Apr 14.

PMID:
28409723
30.

Epigenetics: a new tool for meningioma management?

Sanson M, Kalamarides M.

Lancet Oncol. 2017 May;18(5):569-570. doi: 10.1016/S1470-2045(17)30153-5. Epub 2017 Mar 15. No abstract available.

PMID:
28314686
31.

Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment.

Kalamarides M, Peyre M.

World Neurosurg. 2017 May;101:814.e7-814.e10. doi: 10.1016/j.wneu.2017.03.013. Epub 2017 Mar 12.

PMID:
28300711
32.

Multivariate Analysis of Factors Influencing Facial Nerve Outcome following Microsurgical Resection of Vestibular Schwannoma.

Torres R, Nguyen Y, Vanier A, Smail M, Ferrary E, Sterkers O, Kalamarides M, Bernardeschi D.

Otolaryngol Head Neck Surg. 2017 Mar;156(3):525-533. doi: 10.1177/0194599816677711. Epub 2016 Nov 16.

PMID:
28248607
33.

Medical treatment in neurofibromatosis type 2. Review of the literature and presentation of clinical reports.

Goutagny S, Kalamarides M.

Neurochirurgie. 2018 Nov;64(5):370-374. doi: 10.1016/j.neuchi.2016.09.004. Epub 2017 Feb 3.

PMID:
28162254
34.

SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.

Boetto J, Bielle F, Sanson M, Peyre M, Kalamarides M.

Neuro Oncol. 2017 Mar 1;19(3):345-351. doi: 10.1093/neuonc/now276.

35.

Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.

Valery CA, Faillot M, Lamproglou I, Golmard JL, Jenny C, Peyre M, Mokhtari K, Mazeron JJ, Cornu P, Kalamarides M.

J Neurosurg. 2016 Dec;125(Suppl 1):89-96.

PMID:
27903189
36.

Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.

Ling C, Pouget C, Rech F, Pflaum R, Treffel M, Bielle F, Mokhtari K, Casse JM, Vignaud JM, Kalamarides M, Peyre M, Gauchotte G.

J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1160-1170. doi: 10.1093/jnen/nlw095.

PMID:
27807004
37.

Surgical treatment of sporadic vestibular schwannoma in a series of 1006 patients.

Zhang Z, Nguyen Y, De Seta D, Russo FY, Rey A, Kalamarides M, Sterkers O, Bernardeschi D.

Acta Otorhinolaryngol Ital. 2016 Oct;36(5):408-414. doi: 10.14639/0392-100X-1176.

38.

Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2.

Ouerdani A, Goutagny S, Kalamarides M, Trocóniz IF, Ribba B.

Cancer Chemother Pharmacol. 2016 Jun;77(6):1263-73. doi: 10.1007/s00280-016-3046-2. Epub 2016 May 4.

PMID:
27146400
39.

Internal Auditory Canal Decompression for Hearing Maintenance in Neurofibromatosis Type 2 Patients.

Bernardeschi D, Peyre M, Collin M, Smail M, Sterkers O, Kalamarides M.

Neurosurgery. 2016 Sep;79(3):370-7. doi: 10.1227/NEU.0000000000001125.

PMID:
26579965
40.

PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.

Peyre M, Salaud C, Clermont-Taranchon E, Niwa-Kawakita M, Goutagny S, Mawrin C, Giovannini M, Kalamarides M.

Oncotarget. 2015 Oct 20;6(32):32713-22. doi: 10.18632/oncotarget.5296.

41.

Clinical response associated with radiographic regression of a cervicomedullary ependymoma in a NF2 patient treated by bevacizumab.

Essayed WI, Bernard A, Kalamarides M.

J Neurooncol. 2015 Nov;125(2):445-6. doi: 10.1007/s11060-015-1925-8. Epub 2015 Sep 4. No abstract available.

PMID:
26337624
42.

Natural history of vestibular schwannomas and hearing loss in NF2 patients.

Peyre M, Bernardeschi D, Sterkers O, Kalamarides M.

Neurochirurgie. 2018 Nov;64(5):342-347. doi: 10.1016/j.neuchi.2015.03.012. Epub 2015 Jul 14.

PMID:
26183546
43.

Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.

Pasmant E, Louvrier C, Luscan A, Cohen J, Laurendeau I, Vidaud M, Vidaud D, Goutagny S, Kalamarides M, Parfait B.

Neurochirurgie. 2018 Nov;64(5):335-341. doi: 10.1016/j.neuchi.2015.01.004. Epub 2015 Jun 12.

PMID:
26073919
44.

Effect of corticosteroids on facial function after cerebellopontine angle tumor removal: a double-blind study versus placebo.

Bozorg Grayeli A, Ferrary E, Tubach F, Bernat I, Deguine O, Darrouzet V, Robier A, Zaouche S, Dubreuil C, Marx M, Kalamarides M, Fraysse B, Sterkers O.

Audiol Neurootol. 2015;20(4):213-21. doi: 10.1159/000370191. Epub 2015 Apr 28.

PMID:
25924803
45.

Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.

Peyre M, Zanello M, Mokhtari K, Boch AL, Capelle L, Carpentier A, Clemenceau S, Karachi C, Navarro S, Nouet A, Reina V, Valery CA, Sanson M, Cornu P, Kalamarides M.

J Neurooncol. 2015 May;123(1):151-60. doi: 10.1007/s11060-015-1778-1. Epub 2015 Apr 17.

PMID:
25894596
46.

Multiple meningiomas in patients with Turner syndrome.

Amelot A, Lemaistre G, Cornu P, Kalamarides M, Peyre M.

Acta Neurochir (Wien). 2015 Apr;157(4):621-3. doi: 10.1007/s00701-015-2360-5. Epub 2015 Feb 10. No abstract available.

PMID:
25663140
47.

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Goutagny S, Raymond E, Esposito-Farese M, Trunet S, Mawrin C, Bernardeschi D, Larroque B, Sterkers O, Giovannini M, Kalamarides M.

J Neurooncol. 2015 Apr;122(2):313-20. doi: 10.1007/s11060-014-1710-0. Epub 2015 Jan 8.

48.

Update from the 2013 International Neurofibromatosis Conference.

Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, Parkinson DB, Stemmer-Rachamimov AO, Van Raamsdonk CD, Riccardi VM, Rosser T, Schindeler A, Smith MJ, Stevenson DA, Ullrich NJ, van der Vaart T, Weiss B, Widemann BC, Zhu Y, Bakker AC, Lloyd AC.

Am J Med Genet A. 2014 Dec;164A(12):2969-78. doi: 10.1002/ajmg.a.36754. Epub 2014 Sep 24. No abstract available.

49.

Molecular genetics of meningiomas: Building the roadmap towards personalized therapy.

Peyre M, Kalamarides M.

Neurochirurgie. 2018 Mar;64(1):22-28. doi: 10.1016/j.neuchi.2014.06.007. Epub 2014 Sep 20. Review.

PMID:
25245924
50.

Forestier's disease presenting with dysphagia and disphonia.

Najib J, Goutagny S, Peyre M, Faillot T, Kalamarides M.

Pan Afr Med J. 2014 Mar 6;17:168. doi: 10.11604/pamj.2014.17.168.2453. eCollection 2014.

Supplemental Content

Loading ...
Support Center